International Clinical Trial: Open-label, randomized, cross-over, 3-period study to assess the effect of food on the absorption of oral SCY-770 in healthy volunteers" (Cohort 1)

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ACTRN12626000754347) titled 'Open-label, randomized, cross-over, 3-period study to assess the effect of food on the absorption of oral SCY-770 in healthy volunteers" (Cohort 1)' on June 25.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Crossover

Primary Sponsor: SCYNEXIS, Inc.

Condition: Non-Alcoholic Fatty Liver Disease [NAFLD] Non-Alcoholic Fatty Liver Disease [NAFLD] Metabolic and Endocrine - Metabolic disorders

Intervention: SCY-770 will be provided as tablets for oral administration with 240ml of room temperature water.

Standardi...